sirolimus-coated Bx Velocity stent

DEVICE2 trials

Sponsors

Cordis US Corp.

Conditions

Coronary Artery Disease

Phase 1

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

CompletedNCT00233818

Cordis US Corp.Coronary Artery Disease

Start: 2000-02-29End: 2005-06-30Updated: 2007-10-12

Phase 3

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.

CompletedNCT00235144

Cordis US Corp.Coronary Artery Disease

Start: 2001-03-31End: 2008-09-30Updated: 2009-05-11

Related Papers

5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

2009-09-01100 citations

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.

2007-02-12472 citations